Rockefeller Capital Management
CRMD icon

Rockefeller Capital Management’s CorMedix CRMD Stock Holding History

Rockefeller Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53K Sell
195
-515
-73% -$4.07K ﹤0.01% 4474
2026
Q1 		$4.82K Buy
710
+515
+264% +$3.81K ﹤0.01% 4255
2025
Q4 		$2.27K Buy
+195
New +$2.16K ﹤0.01% 4288

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Rockefeller Capital Management's CRMD Position: Q2 2026 in Review

Rockefeller Capital Management reduced its CorMedix (CRMD) stake by 73% in Q2 2026, selling an estimated $4.07K and leaving 195 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #4474.

Rockefeller Capital Management first reported a position in CRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.82K in Q1 2026. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Rockefeller Capital Management held 195 shares of CorMedix worth $1.53K as of Q2 2026.
  • Rockefeller Capital Management sold 515 CorMedix shares in Q2 2026, an estimated $4.07K.
  • CorMedix made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4474 holding.
  • Rockefeller Capital Management first reported a position in CorMedix in Q4 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's CorMedix position peaked at $4.82K in Q1 2026.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.